269 related articles for article (PubMed ID: 20462963)
1. Kidney disease associated with plasma cell dyscrasias.
Heher EC; Goes NB; Spitzer TR; Raje NS; Humphreys BD; Anderson KC; Richardson PG
Blood; 2010 Sep; 116(9):1397-404. PubMed ID: 20462963
[TBL] [Abstract][Full Text] [Related]
2. Paraprotein-Related Kidney Disease: Kidney Injury from Paraproteins-What Determines the Site of Injury?
Doshi M; Lahoti A; Danesh FR; Batuman V; Sanders PW;
Clin J Am Soc Nephrol; 2016 Dec; 11(12):2288-2294. PubMed ID: 27526707
[TBL] [Abstract][Full Text] [Related]
3. Paraprotein-Related Kidney Disease: Diagnosing and Treating Monoclonal Gammopathy of Renal Significance.
Rosner MH; Edeani A; Yanagita M; Glezerman IG; Leung N;
Clin J Am Soc Nephrol; 2016 Dec; 11(12):2280-2287. PubMed ID: 27526705
[TBL] [Abstract][Full Text] [Related]
4. Light chains: heavy burden in kidney transplantation.
Heher EC; Spitzer TR; Goes NB
Transplantation; 2009 Apr; 87(7):947-52. PubMed ID: 19352111
[TBL] [Abstract][Full Text] [Related]
5. [Renal disorders associated with monoclonal gammopathies: diagnostic and therapeutic progress].
Bridoux F; Delbes S; Sirac C; Pourreau F; Puyade M; Desport E; Jaccard A; Fermand JP; Touchard G
Presse Med; 2012 Mar; 41(3 Pt 1):276-89. PubMed ID: 22244725
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of renal damage in plasma cell dyscrasias: an overview.
Merlini G; Pozzi C
Contrib Nephrol; 2007; 153():66-86. PubMed ID: 17075224
[TBL] [Abstract][Full Text] [Related]
7. The biology of immunoglobulin free light chains and kidney injury.
Basnayake K; Stringer SJ; Hutchison CA; Cockwell P
Kidney Int; 2011 Jun; 79(12):1289-301. PubMed ID: 21490587
[TBL] [Abstract][Full Text] [Related]
8. The spectrum of monoclonal immunoglobulin deposition disease associated with immunocytic dyscrasias.
Gallo G; Picken M; Buxbaum J; Frangione B
Semin Hematol; 1989 Jul; 26(3):234-45. PubMed ID: 2506646
[TBL] [Abstract][Full Text] [Related]
9. [Plasma cell dyscrasias and renal damage].
Pasquali S; Iannuzzella F; Somenzi D; Mattei S; Bovino A; Corradini M
G Ital Nefrol; 2012; 29(1):58-69. PubMed ID: 22388907
[TBL] [Abstract][Full Text] [Related]
10. The kidney in plasma cell dyscrasias: a current view and a look at the future.
Herrera GA
Contrib Nephrol; 2007; 153():1-4. PubMed ID: 17075220
[No Abstract] [Full Text] [Related]
11. Renal and cardiac manifestations of B-cell dyscrasias with nonamyloidotic monoclonal light chain and light and heavy chain deposition diseases.
Gallo GR; Lazowski P; Kumar A; Vidal R; Baldwin DS; Buxbaum JN
Adv Nephrol Necker Hosp; 1998; 28():355-82. PubMed ID: 9889999
[No Abstract] [Full Text] [Related]
12. Renal manifestations of plasma cell dyscrasias: an appraisal from the patients' bedside to the research laboratory.
Herrera GA
Ann Diagn Pathol; 2000 Jun; 4(3):174-200. PubMed ID: 10919389
[TBL] [Abstract][Full Text] [Related]
13. Paraprotein-associated thrombotic microangiopathy: expanding the spectrum of renal disease related to plasma cell dyscrasias.
Lin M; Haas M
Kidney Int; 2017 Mar; 91(3):532-534. PubMed ID: 28202168
[TBL] [Abstract][Full Text] [Related]
14. [The kidney in dysproteinemia].
Spanti D; Marcantoni C; Di Landro D
G Ital Nefrol; 2005; 22 Suppl 33():S39-45. PubMed ID: 16419005
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal gammopathy: significance and possible causality in renal disease.
Paueksakon P; Revelo MP; Horn RG; Shappell S; Fogo AB
Am J Kidney Dis; 2003 Jul; 42(1):87-95. PubMed ID: 12830460
[TBL] [Abstract][Full Text] [Related]
16. [Diagnosis and treatment of kidney involvement in plasma cell diseases : Renal involvement in multiple myeloma and monoclonal gammopathies].
Gödecke V; Schmidt JJ; Bräsen JH; Koenecke C; Haller H
Internist (Berl); 2019 Jan; 60(1):10-22. PubMed ID: 30635666
[TBL] [Abstract][Full Text] [Related]
17. The ultrastructural basis of renal pathology in monoclonal gammopathies.
Santostefano M; Zanchelli F; Zaccaria A; Poletti G; Fusaroli M
J Nephrol; 2005; 18(6):659-75. PubMed ID: 16358223
[TBL] [Abstract][Full Text] [Related]
18. Renal transplant in plasma cell dyscrasias with lenalidomide treatment after autologous stem cell transplantation.
Sánchez Quintana A; Rull PR; Atienza JB; McDonnell CN
Nephrology (Carlton); 2013 Sep; 18(9):641-3. PubMed ID: 23980813
[TBL] [Abstract][Full Text] [Related]
19. Renal lesions associated with plasma cell dyscrasias: practical approach to diagnosis, new concepts, and challenges.
Herrera GA
Arch Pathol Lab Med; 2009 Feb; 133(2):249-67. PubMed ID: 19195968
[TBL] [Abstract][Full Text] [Related]
20. Plasma cell dyscrasia-related glomerulopathies and Fanconi's syndrome: a molecular approach.
Ronco P; Aucouturier P; Mougenot B
J Nephrol; 2000; 13 Suppl 3():S34-44. PubMed ID: 11132031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
